Fibroblastic FAP promotes intrahepatic cholangiocarcinoma growth via MDSCs recruitment

Desmoplasia is a hallmark of intrahepatic cholangiocarcinoma (ICC), which constitutes a barrier to infiltration of lymphocyte, but not myeloid cells. Given that dense desmoplastic stroma has been reported to be a barrier to infiltration of lymphocyte, but not myeloid cells. We here investigated whet...

Full description

Bibliographic Details
Main Authors: Yuli Lin, Bingji Li, Xuguang Yang, Qian Cai, Weiren Liu, Mengxin Tian, Haoyang Luo, Wei Yin, Yan Song, Yinghong Shi, Rui He
Format: Article
Language:English
Published: Elsevier 2019-12-01
Series:Neoplasia: An International Journal for Oncology Research
Online Access:http://www.sciencedirect.com/science/article/pii/S1476558619303136
id doaj-c1944b4530ad4613b1d28b360dc8c5f6
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Yuli Lin
Bingji Li
Xuguang Yang
Qian Cai
Weiren Liu
Mengxin Tian
Haoyang Luo
Wei Yin
Yan Song
Yinghong Shi
Rui He
spellingShingle Yuli Lin
Bingji Li
Xuguang Yang
Qian Cai
Weiren Liu
Mengxin Tian
Haoyang Luo
Wei Yin
Yan Song
Yinghong Shi
Rui He
Fibroblastic FAP promotes intrahepatic cholangiocarcinoma growth via MDSCs recruitment
Neoplasia: An International Journal for Oncology Research
author_facet Yuli Lin
Bingji Li
Xuguang Yang
Qian Cai
Weiren Liu
Mengxin Tian
Haoyang Luo
Wei Yin
Yan Song
Yinghong Shi
Rui He
author_sort Yuli Lin
title Fibroblastic FAP promotes intrahepatic cholangiocarcinoma growth via MDSCs recruitment
title_short Fibroblastic FAP promotes intrahepatic cholangiocarcinoma growth via MDSCs recruitment
title_full Fibroblastic FAP promotes intrahepatic cholangiocarcinoma growth via MDSCs recruitment
title_fullStr Fibroblastic FAP promotes intrahepatic cholangiocarcinoma growth via MDSCs recruitment
title_full_unstemmed Fibroblastic FAP promotes intrahepatic cholangiocarcinoma growth via MDSCs recruitment
title_sort fibroblastic fap promotes intrahepatic cholangiocarcinoma growth via mdscs recruitment
publisher Elsevier
series Neoplasia: An International Journal for Oncology Research
issn 1476-5586
publishDate 2019-12-01
description Desmoplasia is a hallmark of intrahepatic cholangiocarcinoma (ICC), which constitutes a barrier to infiltration of lymphocyte, but not myeloid cells. Given that dense desmoplastic stroma has been reported to be a barrier to infiltration of lymphocyte, but not myeloid cells. We here investigated whether fibroblastic FAP influenced ICC progression via non-T cell-related immune mechanisms. We demonstrated fibroblastic FAP expression was critical for STAT3 activation and CCL2 production, and ICC-CAFs were the primary source of CCL2 in human ICC microenvironment by using ICC-Fbs from six ICC patients. Fibroblastic knockdown of FAP significantly impaired the ability of ICC-CAFs to promote ICC growth, MDSCs infiltration and angiogenesis, which was restored by adding exogenous CCL2. Furthermore, interestingly, the tumor-promoting effect of fibroblastic FAP is dependent on MDSCs via secretion of CCL2, as depletion of Gr-1+ cells reversed the restoring effects of exogenous CCL2 on tumor growth and angiogenesis. In vitro migration assay confirmed that exogenous CCL2 could rescue the impaired ability of ICC-Fbs to attract Gr-1+ cells caused by fibroblastic FAP knockdown. In contrast, fibroblastic FAP knockdown had no effect on ICC cell proliferation and apoptotic resistance. Depletion MDSCs by anti-Gr-1 monoclonal antibody in subcutaneous transplanted tumor model abrogated tumor promotion by ICC-CAFs suggested that the pro-tumor function of Fibroblastic FAP relied on MDSCs. Mechanical, flow cytometry and chamber migration assay were conducted to find Fibroblastic FAP was required by the ability of ICC-CAFs to promote MDSC migration directly. Moreover, fibroblastic FAP knockdown had no effect on cell proliferation and apoptotic resistance. Here, we revealed the T-cell independent mechanisms underlying the ICC-promoting effect of fibroblastic FAP by attracting MDSCs via CCL2, which was mainly attributed to the ability of FAP to attract MDSCs and suggests that specific targeting fibroblastic FAP may represent a promising therapeutic strategy against ICC.
url http://www.sciencedirect.com/science/article/pii/S1476558619303136
work_keys_str_mv AT yulilin fibroblasticfappromotesintrahepaticcholangiocarcinomagrowthviamdscsrecruitment
AT bingjili fibroblasticfappromotesintrahepaticcholangiocarcinomagrowthviamdscsrecruitment
AT xuguangyang fibroblasticfappromotesintrahepaticcholangiocarcinomagrowthviamdscsrecruitment
AT qiancai fibroblasticfappromotesintrahepaticcholangiocarcinomagrowthviamdscsrecruitment
AT weirenliu fibroblasticfappromotesintrahepaticcholangiocarcinomagrowthviamdscsrecruitment
AT mengxintian fibroblasticfappromotesintrahepaticcholangiocarcinomagrowthviamdscsrecruitment
AT haoyangluo fibroblasticfappromotesintrahepaticcholangiocarcinomagrowthviamdscsrecruitment
AT weiyin fibroblasticfappromotesintrahepaticcholangiocarcinomagrowthviamdscsrecruitment
AT yansong fibroblasticfappromotesintrahepaticcholangiocarcinomagrowthviamdscsrecruitment
AT yinghongshi fibroblasticfappromotesintrahepaticcholangiocarcinomagrowthviamdscsrecruitment
AT ruihe fibroblasticfappromotesintrahepaticcholangiocarcinomagrowthviamdscsrecruitment
_version_ 1725031993282920448
spelling doaj-c1944b4530ad4613b1d28b360dc8c5f62020-11-25T01:43:43ZengElsevierNeoplasia: An International Journal for Oncology Research1476-55862019-12-01211211331142Fibroblastic FAP promotes intrahepatic cholangiocarcinoma growth via MDSCs recruitmentYuli Lin0Bingji Li1Xuguang Yang2Qian Cai3Weiren Liu4Mengxin Tian5Haoyang Luo6Wei Yin7Yan Song8Yinghong Shi9Rui He10Department of Immunology and Key Laboratory of Medical Molecular Virology of Ministries of Education and Health, School of Basic Medical Sciences, Fudan University, Shanghai 200032, China; Institutes of Integrative Medicine, Fudan University, ChinaDepartment of Immunology and Key Laboratory of Medical Molecular Virology of Ministries of Education and Health, School of Basic Medical Sciences, Fudan University, Shanghai 200032, ChinaCancer Institute, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, ChinaDepartment of Immunology and Key Laboratory of Medical Molecular Virology of Ministries of Education and Health, School of Basic Medical Sciences, Fudan University, Shanghai 200032, ChinaKey Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, Department of Liver Surgery, Liver Cancer Institute, Zhongshan Hospital, Shanghai, 20032, ChinaKey Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, Department of Liver Surgery, Liver Cancer Institute, Zhongshan Hospital, Shanghai, 20032, ChinaDepartment of Immunology and Key Laboratory of Medical Molecular Virology of Ministries of Education and Health, School of Basic Medical Sciences, Fudan University, Shanghai 200032, ChinaDepartment of Immunology and Key Laboratory of Medical Molecular Virology of Ministries of Education and Health, School of Basic Medical Sciences, Fudan University, Shanghai 200032, ChinaDepartment of Immunology and Key Laboratory of Medical Molecular Virology of Ministries of Education and Health, School of Basic Medical Sciences, Fudan University, Shanghai 200032, ChinaKey Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, Department of Liver Surgery, Liver Cancer Institute, Zhongshan Hospital, Shanghai, 20032, China; Corresponding authors.Department of Immunology and Key Laboratory of Medical Molecular Virology of Ministries of Education and Health, School of Basic Medical Sciences, Fudan University, Shanghai 200032, China; Corresponding authors.Desmoplasia is a hallmark of intrahepatic cholangiocarcinoma (ICC), which constitutes a barrier to infiltration of lymphocyte, but not myeloid cells. Given that dense desmoplastic stroma has been reported to be a barrier to infiltration of lymphocyte, but not myeloid cells. We here investigated whether fibroblastic FAP influenced ICC progression via non-T cell-related immune mechanisms. We demonstrated fibroblastic FAP expression was critical for STAT3 activation and CCL2 production, and ICC-CAFs were the primary source of CCL2 in human ICC microenvironment by using ICC-Fbs from six ICC patients. Fibroblastic knockdown of FAP significantly impaired the ability of ICC-CAFs to promote ICC growth, MDSCs infiltration and angiogenesis, which was restored by adding exogenous CCL2. Furthermore, interestingly, the tumor-promoting effect of fibroblastic FAP is dependent on MDSCs via secretion of CCL2, as depletion of Gr-1+ cells reversed the restoring effects of exogenous CCL2 on tumor growth and angiogenesis. In vitro migration assay confirmed that exogenous CCL2 could rescue the impaired ability of ICC-Fbs to attract Gr-1+ cells caused by fibroblastic FAP knockdown. In contrast, fibroblastic FAP knockdown had no effect on ICC cell proliferation and apoptotic resistance. Depletion MDSCs by anti-Gr-1 monoclonal antibody in subcutaneous transplanted tumor model abrogated tumor promotion by ICC-CAFs suggested that the pro-tumor function of Fibroblastic FAP relied on MDSCs. Mechanical, flow cytometry and chamber migration assay were conducted to find Fibroblastic FAP was required by the ability of ICC-CAFs to promote MDSC migration directly. Moreover, fibroblastic FAP knockdown had no effect on cell proliferation and apoptotic resistance. Here, we revealed the T-cell independent mechanisms underlying the ICC-promoting effect of fibroblastic FAP by attracting MDSCs via CCL2, which was mainly attributed to the ability of FAP to attract MDSCs and suggests that specific targeting fibroblastic FAP may represent a promising therapeutic strategy against ICC.http://www.sciencedirect.com/science/article/pii/S1476558619303136